World's Best Scientists 2026 revealed!
Andrew D. Clouston

Andrew D. Clouston

D-Index & Metrics

Medicine

D-Index
77
Citations
21211
World Ranking
18454
National Ranking
611

Overview

Andrew D. Clouston is affiliated with the University of Queensland in Australia and contributes significantly to the field of medicine, with a primary focus on hepatology and related biomedical sciences.

The scientist's research spans several subfields, including:

  • Epidemiology
  • Hepatology
  • Immunology
  • Oncology
  • Molecular Biology

Key topics addressed in their work cover:

  • Liver Disease Diagnosis and Treatment
  • Hematopoietic Stem Cell Transplantation
  • Liver Diseases and Immunity
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Immune Cell Function and Interaction
  • Liver Disease and Transplantation
  • Liver physiology and pathology

Frequent co-authors contributing to the collaborative research include:

  • David E. Kleiner
  • Geoffrey R. Hill
  • Kathleen S. Ensbey
  • Dina Tiniakos
  • Elizabeth E. Powell

The scientist's work is often published in established venues, notably:

  • Journal of Hepatology
  • Blood
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Liver International
  • JHEP Reports

Notable recent research papers authored or co-authored by Andrew D. Clouston include:

  • "Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD," 2022, Journal of Hepatology
  • "Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group," 2022, Liver International
  • "ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis," 2021, JHEP Reports
  • "DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association," 2021, Communications Biology
  • "ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice," 2020, Hepatology Communications

Best Publications

  • Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.

    Vinod P. Balachandran;Marta Łuksza;Julia N. Zhao;Vladimir Makarov

  • Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial

    Andrew R. L. Stevenson;Andrew R. L. Stevenson;Michael J. Solomon;John W. Lumley;Peter Hewett

  • Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

    Luke F. Hourigan;Graeme A. Macdonald;David Purdie;Vicki H. Whitehall

  • Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel.

    Anthony Demetris;David Adams;Chris Bellamy;Karin Blakolmer

  • Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life

    I J Hickman;J R Jonsson;J B Prins;S Ash

  • Host genetic factors influence disease progression in chronic hepatitis C

    Elizabeth E. Powell;Catherine J. Edwards-Smith;John L. Hay;Andrew D. Clouston

  • An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation

    Kelli P. A. MacDonald;James S. Palmer;Stephen Cronau;Elke Jane Seppanen

  • The serrated pathway to colorectal carcinoma: current concepts and challenges.

    Mark Bettington;Mark Bettington;Neal Walker;Andrew Clouston;Ian Brown

  • Progressive Fibrosis in Nonalcoholic Steatohepatitis: Association With Altered Regeneration and a Ductular Reaction

    Michelle M Richardson;Julie R Jonsson;Elizabeth E Powell;Elizabeth M Brunt

  • Steatosis: Co-factor in other liver diseases

    Elizabeth E. Powell;Julie R. Jonsson;Andrew D. Clouston

  • The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease

    Victoria L. Gadd;Richard Skoien;Elizabeth E. Powell;Kevin J. Fagan

  • Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C

    I J Hickman;A D Clouston;G A Macdonald;D M Purdie

  • Fibrosis correlates with a ductular reaction in hepatitis C: Roles of impaired replication, progenitor cells and steatosis

    Andrew D. Clouston;Elizabeth E. Powell;Elizabeth E. Powell;Meagan J. Walsh;Michelle M. Richardson

  • Angiotensin-Converting Enzyme Inhibition Attenuates the Progression of Rat Hepatic Fibrosis

    Julie R. Jonsson;Andrew D. Clouston;Yuichi Ando;Livia I. Kelemen

  • Non‐response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS‐3) in patients with chronic hepatitis C, viral genotype 1

    Meagan J Walsh;Julie R Jonsson;Michelle M Richardson;Geraldine Lipka

  • Links Between Hepatic Fibrosis, Ductular Reaction, and Progenitor Cell Expansion

    Michael J. Williams;Andrew D. Clouston;Stuart J. Forbes

  • Ductular reactions in human liver: Diversity at the interface

    Annette S. H. Gouw;Andrew D. Clouston;Neil D. Theise

  • Disease-free Survival and Local Recurrence After Laparoscopic-assisted Resection or Open Resection for Rectal Cancer: The Australasian Laparoscopic Cancer of the Rectum Randomized Clinical Trial.

    Andrew R. L. Stevenson;Andrew R. L. Stevenson;Michael J. Solomon;Christopher S. B. Brown;John W. Lumley

  • Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome

    D. L. Worthley;K. D. Phillips;N. Wayte;K. A. Schrader

  • Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease

    Motoko Koyama;Rachel D Kuns;Stuart D Olver;Neil C Raffelt

Frequent Co-Authors

Geoffrey R. Hill
Geoffrey R. Hill Fred Hutchinson Cancer Research Center
Kelli P. A. MacDonald
Kelli P. A. MacDonald QIMR Berghofer Medical Research Institute
Darrell H. G. Crawford
Darrell H. G. Crawford University of Queensland
David M. Purdie
David M. Purdie Global Blood Therapeutics (United States)
Bruce R. Blazar
Bruce R. Blazar University of Minnesota
Barbara A. Leggett
Barbara A. Leggett University of Queensland
Geoffrey W. McCaughan
Geoffrey W. McCaughan University of Sydney
Gregory J. Anderson
Gregory J. Anderson QIMR Berghofer Medical Research Institute
Christian R. Engwerda
Christian R. Engwerda QIMR Berghofer Medical Research Institute
James G. Kench
James G. Kench Royal Prince Alfred Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

There are a variety of online degrees available for students interested in healthcare, offering flexibility without compromising quality. One option for those drawn to healthcare leadership is a program recognized as a cahme accredited MHA, which ensures rigorous standards in health administration education.

Nurses seeking career advancement may consider online rn to bsn programs without clinicals, making it easier for working professionals to complete a degree online without the need for in-person clinical hours. For nurses aspiring to higher leadership or advanced practice roles, the shortest msn to dnp program offers a fast-track to a Doctor of Nursing Practice degree.

For those balancing work and study, some online dnp programs without clinicals make it possible to earn a doctorate in nursing without on-site requirements. Exploring these alternatives can open new doors for professionals in healthcare, whether you’re focusing on patient care, administration, or educational roles.

Best Scientists Citing Andrew D. Clouston

Trending Scientists